Key result
Chitosan reduces LDL cholesterol by ~/dl more than placebo without altering synthesis markers.
RCT (n=116)
Placebo-controlled
Answers are grounded in this paper and cite their sources.
Demonstrates that chitosan lowers LDL cholesterol in obese individuals without altering standard cholesterol absorption or synthesis markers, highlighting an unexpected metabolic mechanism.
Chitosan treatment results in significantly lower plasma LDL-cholesterol concentrations. To test the working mechanism of Chitosan, we measured plasma surrogate markers of cholesterol absorption, synthesis, and degradation to bile acids corrected for cholesterol concentration (R_sterols). One hundred sixteen obese subjects (BMI 31.7, range 28.1 – 38.9 kg/m2) were studied under Chitosan treatment (n=61) and placebo treatment (n=55) during 12 weeks. The participants underwent a short nutrition education on how to improve quality of nutrition and energy expenditure. Daily Chitosan intake was 3200 mg. RESULTS. Plasma LDL-cholesterol concentration decreased significantly stronger (P=0.0252) under Chitosan (-8.67 ± 18.18 mg/dl, 5.6%) than under placebo treatment (-1.00 ± 24.22 mg/dl, 0.9%). This reduction was not associated with corresponding decreases of markers of cholesterol absorption under Chitosan treatment. As a marker for cholesterol synthesis R_lathosterol showed a trend towards a stronger decrease under Chitosan treatment (P=0.0759). Regarding markers of bile acid synthesis, R_7α-hydroxy-cholesterol decreased significantly only under Chitosan treatment, but not stronger than under placebo treatment. In conclusion, a significant selective reduction of plasma LDL-cholesterol under Chitosan treatment is neither associated with an expected reduction of plasma surrogate markers of cholesterol absorption nor with expected increases of markers for cholesterol and bile acid synthesis.
No takes yet. Share an insight, caveat, or question.
Lütjohann et al. (2018) conducted an RCT in Obesity (n=116). Chitosan vs. Placebo was evaluated on Change in plasma LDL-cholesterol concentration (p=0.0252). Chitosan treatment reduced plasma LDL-cholesterol more than placebo without altering cholesterol absorption or synthesis markers.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: